Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed…
New Survey Finds Younger Adults, More Women Seeking Treatment for Hair Loss
Manageable number of monthly hair restoration surgeries illustrates ISHRS members' hands-on, expert approach…
